388
Views
5
CrossRef citations to date
0
Altmetric
Mouth/Pharynx

Inflammatory Bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization

, , , , , & ORCID Icon show all
Pages 191-196 | Received 06 Dec 2021, Accepted 21 Jan 2022, Published online: 23 Feb 2022

References

  • Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67(1):51–64.
  • Ellington TD, Henley SJ, Senkomago V, et al. Trends in incidence of cancers of the oral cavity and Pharynx – United States 2007–2016. MMWR Morb Mortal Wkly Rep. 2020;69(15):433–438.
  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778.
  • Nissen LHC, Derikx LAAP, Jacobs AME, et al. Risk factors and clinical outcomes of head and neck cancer in inflammatory bowel disease: a nationwide cohort study. Inflamm Bowel Dis. 2018;24(9):2015–2026.
  • Smith GD, Ebrahim S. Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22.
  • Vithayathil M, Carter P, Kar S, et al. Body size and composition and risk of site-specific cancers in the UK biobank and large international consortia: a mendelian randomisation study. PLoS Med. 2021;18(7):e1003706.
  • Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979–986.
  • Papadimitriou N, Dimou N, Tsilidis KK, et al. Physical activity and risks of breast and colorectal cancer: a mendelian randomisation analysis. Nat Commun. 2020;11(1):597.
  • Lesseur C, Diergaarde B, Olshan AF, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48(12):1544–1550.
  • Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.
  • Gormley M, Dudding T, Sanderson E, et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020;11(1):6071.
  • Nyboe Andersen N, Pasternak B, Friis-Møller N, et al. Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide danish cohort study. BMJ. 2015;350:h2809.
  • Katsanos KH, Roda G, Brygo A, et al. Oral cancer and oral precancerous lesions in inflammatory bowel diseases: a systematic review. J Crohns Colitis. 2015;9(11):1043–1052.
  • Byrd KM, Gulati AS. The “Gum-Gut” axis in inflammatory bowel diseases: a hypothesis-driven review of associations and advances. Front Immunol. 2021;12:620124.
  • Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22(20):4794–4801.
  • Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011;140(6):1807–1816.
  • Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis. 2015;21(2):409–418.
  • Beaugerie L, Rahier JF, Kirchgesner J. Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18(6):1324–1335.e2.
  • Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.